MENU 
EQA Catalogue Groups
(Click on a colour/icon to filter calendar entries)
Clinical Genetics and Genetic Counselling
Genomic and Inherited Disorders
Haematological Neoplasms
Individual Competency Assessment
Molecular Newborn Screening
Molecular Pathology
Multidisciplinary team (MDT) working
Pharmacogenomics
Preimplantation Genetic Testing (PGT)
Reproductive Genomics
Sample Handling
Technical (Next Generation Sequencing)
Variant Classification
Viral Sequencing
Other Events
GenQA EQA Enrolment Event
GenQA EQA Distribution Event
GenQA webinar
Conference
GenQA workshop
GenQA Participant meeting
GenQA office closed
Other
| «prev October 2025 next»
| ||||||
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
| Sun 28 | Mon 29
Distribution 16 OPEN
2025 Cystic Fibrosis (CF) Molecular Newborn screening (bloodspots) round 3 - OPENS Testing Period: 4 weeks
2025 MCADD Molecular Newborn Screening (bloodspots) round 3 - OPENS Testing Period: 4 weeks
2025 SCID Molecular Newborn Screening (bloodspots) round 3 - OPENS Testing Period: 4 weeks
2025 Spinal Muscular Atrophy (SMA) Molecular Newborn screening (bloodspots) round 3 - OPENS Testing Period: 4 weeks
2025 Reproductive carrier screening (pilot) - OPENS Testing Period: 8 weeks | Tue 30 | Wed 1 | Thu 2 | Fri 3
2025 Trio Sequencing - Postnatal (neonatal and paediatric) - CLOSES
2025 SARS-CoV-2 sequencing - Distribution 5890 - round 2 - CLOSES | Sat 4 |
| Sun 5 | Mon 6
Distribution 17 OPEN
2025 Interpretation of RNA splicing variants - OPENS Testing Period: 6 weeks
2025 Classification and interpretation of germline CNVs - OPENS Testing Period: 5 weeks
2025 Classification and interpretation of germline SNVs and indels - OPENS Testing Period: 6 weeks
2025 Classification of germline SNVs and indels - OPENS Testing Period: 6 weeks
2025 Classification of haematological neoplasm SNVs, CNVs and SVs (pilot) - OPENS Testing Period: 6 weeks
2025 Classification of somatic solid tumour SNVs, CNVs and SVs (pilot) - OPENS Testing Period: 6 weeks
2025 ISCN (International System for Human Cytogenomic Nomenclature) (pilot) Round 2 - OPENS Testing Period: 6 weeks
2025 Non-invasive prenatal testing (NIPT) for aneuploidies - OPENS Testing Period: 6 weeks
2025 Non-invasive prenatal testing (NIPT) for common microdeletions - OPENS Testing Period: 6 weeks
2025 Non-invasive prenatal testing (NIPT) for fetal sexing - OPENS Testing Period: 6 weeks | Tue 7 | Wed 8 | Thu 9 | Fri 10
2025 Chronic Lymphocytic Leukaemia (CLL) - CLOSES
2025 Chronic Lymphocytic Leukaemia (CLL) IGHV mutation status - CLOSES
2025 Chronic Lymphocytic Leukaemia (CLL) TP53 mutation analysis - CLOSES
2025 Lymphoma - CLOSES | Sat 11 |
| Sun 12 | Mon 13
Distribution 18 OPEN
| Tue 14 | Wed 15 | Thu 16 | Fri 17
2025 Pregnancy loss - CLOSES
2025 Prenatal constitutional Copy Number Variant (CNV) detection - CLOSES
2025 Prenatal karyotyping - CLOSES
2025 Preimplantation genetic testing for aneuploidies (PGT-A) - CLOSES
2025 Preimplantation genetic testing for structural rearrangements (PGT-SR) - CLOSES | Sat 18 |
| Sun 19 | Mon 20
Distribution 19 OPEN
2025 Breast cancer - OPENS Testing Period: 6 weeks
2025 Gastrointestinal stromal tumours (GIST) - OPENS Testing Period: 6 weeks
2025 Homologous recombination repair (HRD) testing (pilot) - OPENS Testing Period: 6 weeks
2025 Lung cancer - fusions (FISH/IHC) - OPENS Testing Period: 6 weeks
2025 Lung cancer - fusions (molecular) - OPENS Testing Period: 6 weeks
2025 Sarcoma - OPENS Testing Period: 6 weeks
2025 Thyroid cancer - OPENS Testing Period: 6 weeks | Tue 21 | Wed 22 | Thu 23 | Fri 24
2025 Cystic Fibrosis (CF) Molecular Newborn screening (bloodspots) round 3 - CLOSES
2025 MCADD Molecular Newborn Screening (bloodspots) round 3 - CLOSES
2025 SCID Molecular Newborn Screening (bloodspots) round 3 - CLOSES
2025 Spinal Muscular Atrophy (SMA) Molecular Newborn screening (bloodspots) round 3 - CLOSES | Sat 25 |
| Sun 26 | Mon 27 | Tue 28 | Wed 29 | Thu 30 | Fri 31 | Sat 1 |
7872
NEWSLETTER SIGN UP